Kris Bauchmuller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kris Bauchmuller has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
D. Miller
3 shared publications- David G. Kiely
School of Medicine & Population Health, The University of Sheffield, Sheffield S10 2TN, UK
3 shared publications - Monika Engelhardt
Universitätsklinikum Freiburg
3 shared publications - Robin Condliffe
Sheffield Teaching Hospitals NHS Foundation Trust
3 shared publications Eva-Susanne Strobel
Department of Hematology and Oncology, University Medical Center, Hugstetter Strasse 55, D-79106, Freiburg; St. Georg Vorsorge- und Rehabilitationskliniken, Kurhausplatz 1, D-79862, Höchenschwand
2 shared publicationsGary H. Mills
Dept of Critical Care, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
2 shared publications
Latest Publications
- 22 December 2025
- Published by Wiley in Anaesthesia
- Vol. 81 (7) , 1020
Challenging the default use of arterial catheters in critical care
- 22 December 2025
- Published by Wiley in Anaesthesia
- Vol. 81 (7) , 1020
Challenging the default use of arterial catheters in critical care
- 20 September 2023
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
- Vol. 44 (06) , 797-809
Surgery and Anesthesia in Patients with Pulmonary Hypertension
Pulmonary hypertension is characterized by right ventricular impairment and a reduced ability to compensate for hemodynamic insults. Consequently, surgery can be challenging but is increasingly considered in view of available specific therapies and improved longer term survival. Optimal management requires a multidisciplinary patient-centered approach involving surgeons, anesthetists, pulmonary hypertension clinicians, and intensivists. The optimal pathway involves risk:benefit assessment for the proposed operation, optimization of pulmonary hypertension and any comorbidities, the appropriate anesthetic approach for the specific procedure and patient, and careful monitoring and management in the postoperative period. Where patients are carefully selected and meticulously managed, good outcomes can be achieved. * Equal contribution. Article published online: 20 September 2023 © 2023. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- 20 September 2023
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
- Vol. 44 (06) , 797-809
Surgery and Anesthesia in Patients with Pulmonary Hypertension
Pulmonary hypertension is characterized by right ventricular impairment and a reduced ability to compensate for hemodynamic insults. Consequently, surgery can be challenging but is increasingly considered in view of available specific therapies and improved longer term survival. Optimal management requires a multidisciplinary patient-centered approach involving surgeons, anesthetists, pulmonary hypertension clinicians, and intensivists. The optimal pathway involves risk:benefit assessment for the proposed operation, optimization of pulmonary hypertension and any comorbidities, the appropriate anesthetic approach for the specific procedure and patient, and careful monitoring and management in the postoperative period. Where patients are carefully selected and meticulously managed, good outcomes can be achieved. * Equal contribution. Article published online: 20 September 2023 © 2023. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
- Open Access
- 1 January 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (1)
Reply: External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension
We were very interested to read the correspondence by M.V.F. Garcia and colleagues [1]. They have assessed our previously proposed predictive score for outcomes in medically decompensated pulmonary hypertension (PH) patients: the OPALS score (oxygen (oxygen saturation measured by pulse oximetry/inspiratory oxygen fraction ratio ⩽185), platelets ⩽196×109 L−1, age ⩾37.5 years, lactate ⩾2.45 mmol·L−1 and sodium ⩽130.5 mmol·L−1) in 74 PH patients. Discriminatory power was very similar to that observed in our derivation cohort (c-statistic of 0.77 versus 0.78) [2]. Furthermore, there was exceedingly high calibration between predicted and observed mortality in their validation cohort (R2=0.97). The OPALS score therefore appears to be a promising PH-specific tool for predicting outcomes in medically decompensated patients. Further work is, however, needed to compare its accuracy and utility compared with other intensive care unit (ICU) scoring systems and PH risk-stratification tools, and to assess its responsiveness to changing clinical severity during patients’ ICU admission.
- 1 January 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (1)
Open AccessReply: External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension
We were very interested to read the correspondence by M.V.F. Garcia and colleagues [1]. They have assessed our previously proposed predictive score for outcomes in medically decompensated pulmonary hypertension (PH) patients: the OPALS score (oxygen (oxygen saturation measured by pulse oximetry/inspiratory oxygen fraction ratio ⩽185), platelets ⩽196×109 L−1, age ⩾37.5 years, lactate ⩾2.45 mmol·L−1 and sodium ⩽130.5 mmol·L−1) in 74 PH patients. Discriminatory power was very similar to that observed in our derivation cohort (c-statistic of 0.77 versus 0.78) [2]. Furthermore, there was exceedingly high calibration between predicted and observed mortality in their validation cohort (R2=0.97). The OPALS score therefore appears to be a promising PH-specific tool for predicting outcomes in medically decompensated patients. Further work is, however, needed to compare its accuracy and utility compared with other intensive care unit (ICU) scoring systems and PH risk-stratification tools, and to assess its responsiveness to changing clinical severity during patients’ ICU admission.
- Open Access
- 18 February 2021
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 7 (2)
Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Pulmonary hypertension (PH) is a life-shortening condition characterised by episodes of decompensation precipitated by factors such as disease progression, arrhythmias and sepsis. Surgery and pregnancy also place additional strain on the right ventricle. Data on critical care management in patients with pre-existing PH are scarce.We conducted a retrospective observational study of a large cohort of patients admitted to the critical care unit of a national referral centre between 2000–2017 to establish acute mortality, evaluate predictors of in-hospital mortality and establish longer term outcomes in survivors to hospital discharge.242 critical care admissions involving 206 patients were identified. Hospital survival was 59.3%, 94% and 92% for patients admitted for medical, surgical or obstetric reasons, respectively. Medical patients had more severe physiological and laboratory perturbations than patients admitted following surgical or obstetric interventions. Higher APACHE II (Acute Physiology and Chronic Health Evaluation) score, age and lactate, and lower oxygen saturation measure by pulse oximetry/inspiratory oxygen fraction (SpO2/FiO2) ratio, platelet count and sodium level were identified as independent predictors of hospital mortality. An exploratory risk score, OPALS (oxygen (SpO2/FiO2) ≤185; platelets ≤196×109·L−1; age ≥37.5 years; lactate ≥2.45 mmol·L−1; sodium ≤130.5 mmol·L−1), identified medical patients at increasing risk of hospital mortality. One (11%) out of nine patients who were invasively ventilated for medical decompensation and 50% of patients receiving renal replacement therapy left hospital alive. There was no significant difference in exercise capacity or functional class between follow-up and pre-admission in patients who survived to discharge.These data have clinical utility in guiding critical care management of patients with known PH. The exploratory OPALS score requires validation.
- 18 February 2021
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 7 (2)
Open AccessCritical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry
Pulmonary hypertension (PH) is a life-shortening condition characterised by episodes of decompensation precipitated by factors such as disease progression, arrhythmias and sepsis. Surgery and pregnancy also place additional strain on the right ventricle. Data on critical care management in patients with pre-existing PH are scarce.We conducted a retrospective observational study of a large cohort of patients admitted to the critical care unit of a national referral centre between 2000–2017 to establish acute mortality, evaluate predictors of in-hospital mortality and establish longer term outcomes in survivors to hospital discharge.242 critical care admissions involving 206 patients were identified. Hospital survival was 59.3%, 94% and 92% for patients admitted for medical, surgical or obstetric reasons, respectively. Medical patients had more severe physiological and laboratory perturbations than patients admitted following surgical or obstetric interventions. Higher APACHE II (Acute Physiology and Chronic Health Evaluation) score, age and lactate, and lower oxygen saturation measure by pulse oximetry/inspiratory oxygen fraction (SpO2/FiO2) ratio, platelet count and sodium level were identified as independent predictors of hospital mortality. An exploratory risk score, OPALS (oxygen (SpO2/FiO2) ≤185; platelets ≤196×109·L−1; age ≥37.5 years; lactate ≥2.45 mmol·L−1; sodium ≤130.5 mmol·L−1), identified medical patients at increasing risk of hospital mortality. One (11%) out of nine patients who were invasively ventilated for medical decompensation and 50% of patients receiving renal replacement therapy left hospital alive. There was no significant difference in exercise capacity or functional class between follow-up and pre-admission in patients who survived to discharge.These data have clinical utility in guiding critical care management of patients with known PH. The exploratory OPALS score requires validation.
- Open Access
- 7 January 2020
- Published by SAGE Publications in Journal of the Intensive Care Society
- Vol. 21 (3) , 256-268
Haemophagocytic lymphohistiocytosis in adult critical care
Haemophagocytic lymphohistiocytosis (HLH) is a syndrome of severe immune dysregulation, characterised by extreme inflammation, fever, cytopaenias and organ dysfunction. HLH can be triggered by conditions such as infection, autoimmune disease and malignancy, among others. Both a familial and a secondary form have been described, the latter being increasingly recognised in adult patients with critical illness. HLH is difficult to diagnose, often under-recognised and carries a high mortality. Patients can present in a very similar fashion to sepsis and the two syndromes can co-exist and overlap, yet HLH requires specific immunosuppressive therapy. HLH should be actively excluded in patients with presumed sepsis who either lack a clear focus of infection or who are not responding to energetic infection management. Elevated serum ferritin is a key biomarker that may indicate the need for further investigations for HLH and can guide treatment. Early diagnosis and a multidisciplinary approach to HLH management may save lives.
- 7 January 2020
- Published by SAGE Publications in Journal of the Intensive Care Society
- Vol. 21 (3) , 256-268
Open AccessHaemophagocytic lymphohistiocytosis in adult critical care
Haemophagocytic lymphohistiocytosis (HLH) is a syndrome of severe immune dysregulation, characterised by extreme inflammation, fever, cytopaenias and organ dysfunction. HLH can be triggered by conditions such as infection, autoimmune disease and malignancy, among others. Both a familial and a secondary form have been described, the latter being increasingly recognised in adult patients with critical illness. HLH is difficult to diagnose, often under-recognised and carries a high mortality. Patients can present in a very similar fashion to sepsis and the two syndromes can co-exist and overlap, yet HLH requires specific immunosuppressive therapy. HLH should be actively excluded in patients with presumed sepsis who either lack a clear focus of infection or who are not responding to energetic infection management. Elevated serum ferritin is a key biomarker that may indicate the need for further investigations for HLH and can guide treatment. Early diagnosis and a multidisciplinary approach to HLH management may save lives.
- Open Access
- 5 May 2016
- Published by Elsevier in BJA Education
- Vol. 16 (9) , 299-304
Non-invasive ventilation in the perioperative period
Maintenance of adequate perioperative respiratory function is of paramount importance for the safe delivery of anaesthesia and surgery and an uneventful recovery thereafter. Optimized tissue oxygenation plays a pivotal role in the preservation of organ function and is vital for wound healing and the protection of surgical anastomoses.
- 5 May 2016
- Published by Elsevier in BJA Education
- Vol. 16 (9) , 299-304
Open AccessNon-invasive ventilation in the perioperative period
Maintenance of adequate perioperative respiratory function is of paramount importance for the safe delivery of anaesthesia and surgery and an uneventful recovery thereafter. Optimized tissue oxygenation plays a pivotal role in the preservation of organ function and is vital for wound healing and the protection of surgical anastomoses.
- Top Cited PapersOpen Access
- 20 April 2016
- Published by Springer Nature in Critical Care
- Vol. 20 (S2) , 94
36th International Symposium on Intensive Care and Emergency Medicine
P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux
- 20 April 2016
- Published by Springer Nature in Critical Care
- Vol. 20 (S2) , 94
Top Cited PapersOpen Access36th International Symposium on Intensive Care and Emergency Medicine
P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux
- Open Access
- 3 November 2015
- Published by Wiley in Anaesthesia
- Vol. 71 (1) , 58-66
The feasibility of using ‘bring your own device’ ( BYOD ) technology for electronic data capture in multicentre medical audit and research
Summary: Large‐scale audit and research projects demand robust, efficient systems for accurate data collection, handling and analysis. We utilised a multiplatform ‘bring your own device’ ( BYOD ) electronic data collection app to capture observational audit data on theatre efficiency across seven hospital Trusts in South Yorkshire in June–August 2013. None of the participating hospitals had a dedicated information governance policy for bring your own device. Data were collected by 17 investigators for 392 individual theatre lists, capturing 14 148 individual data points, 12 852 (91%) of which were transmitted to a central database on the day of collection without any loss of data. BYOD technology enabled accurate collection of a large volume of secure data across multiple NHS organisations over a short period of time. Bring your own device technology provides a method for collecting real‐time audit, research and quality improvement data within healthcare systems without compromising patient data protection.
- 3 November 2015
- Published by Wiley in Anaesthesia
- Vol. 71 (1) , 58-66
Open AccessThe feasibility of using ‘bring your own device’ ( BYOD ) technology for electronic data capture in multicentre medical audit and research
Summary: Large‐scale audit and research projects demand robust, efficient systems for accurate data collection, handling and analysis. We utilised a multiplatform ‘bring your own device’ ( BYOD ) electronic data collection app to capture observational audit data on theatre efficiency across seven hospital Trusts in South Yorkshire in June–August 2013. None of the participating hospitals had a dedicated information governance policy for bring your own device. Data were collected by 17 investigators for 392 individual theatre lists, capturing 14 148 individual data points, 12 852 (91%) of which were transmitted to a central database on the day of collection without any loss of data. BYOD technology enabled accurate collection of a large volume of secure data across multiple NHS organisations over a short period of time. Bring your own device technology provides a method for collecting real‐time audit, research and quality improvement data within healthcare systems without compromising patient data protection.
- 1 April 2015
- Published by Elsevier in Surgery (Oxford)
- Vol. 33 (4) , 165-171
Care of the critically ill patient
- 1 April 2015
- Published by Elsevier in Surgery (Oxford)
- Vol. 33 (4) , 165-171
Care of the critically ill patient
- Open Access
- 12 March 2015
- Published by Wiley in Anaesthesia
- Vol. 70 (4) , 504-505
Regional service evaluation of echocardiography trainers
- 12 March 2015
- Published by Wiley in Anaesthesia
- Vol. 70 (4) , 504-505
Open AccessRegional service evaluation of echocardiography trainers